Adolf C, Asbach E, Dietz AS, Lang K, Hahner S, Quinkler M, Rump LC, Bidlingmaier M, Treitl M, Ladurner R, Beuschlein F, Reincke M. Worsening of lipid metabolism after successful treatment of primary aldosteronism. Endocrine. 2016;54:198-205. (IF 3.131)
Andersen K, Kesper MS, Marschner JA, Konrad L, Ryu M, Kumar Vr S, Kulkarni OP, Mulay SR, Romoli S, Demleitner J, Schiller P, Dietrich A, Müller S, Gross O, Ruscheweyh HJ, Huson DH, Stecher B, Anders HJ. Intestinal dysbiosis, barrier dysfunction, and bacterial translocation account for CKD-related systemic inflammation. J Am Soc Nephrol. Epub 2016 May 5. (IF 8.966)
Anz D, Dichtl K, Bogner J. 25-Jährige mit hohem Fieber. MMW Fortschr Med. 2016;158:83. (IF -) Beuschlein F, Jakoby J, Mentz S, Zambetti G, Jung S, Reincke M, Süss R, Hantel C. IGF1-R inhibition and liposomal doxorubicin: Progress in preclinical evaluation for the treatment of adrenocortical carcinoma. Mol Cell Endocrinol. 2016;428:82-8. (IF 3.754)
Blüm P, Pircher J, Merkle M, Czermak T, Ribeiro A, Mannell H, Krötz F, Hennrich A, Spannagl M, Köppel S, Gaitzsch E, Wörnle M. Arterial thrombosis in the context of HCV-associated vascular disease can be prevented by protein C. Cell Mol Immunol. Epub 2016 Apr 18. (IF 5.897) Brey FL, Seybold U, Kollan C, Bogner JR; ClinSurv-HIV Study Group. Accelerated CD4 decline in untreated HIV-1 patients points toward increasing virulence over the course of the epidemic.
AIDS. 2016;30,1995-7. (IF 5.003)
Degenhart C, Schneller J, Osswald A, Pallauf A, Riester A, Reiser MF, Reincke M, Beuschlein F. Volumetric and densitometric evaluation of the adrenal glands in patients with primary aldosteronism. Clin Endocrinol. Epub 2016 Nov 17. (IF 3.327)
Desai J, Kumar SV, Mulay SR, Konrad L, Romoli S, Schauer C, Herrmann M, Bilyy R, Müller S, Popper B, Nakazawa D, Weidenbusch M, Thomasova D, Krautwald S, Linkermann A, Anders HJ. PMA and crystal-induced neutrophil extracellular trap formation involves RIPK1-RIPK3-MLKL signaling. Eur J Immunol. 2016;46:223-9 (IF 4.227)
Devarapu SK, Kumar Vr S, Rupanagudi KV, Kulkarni OP, Eulberg D, Klussmann S, Anders HJ. Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis.
Clin Immunol. 2016;169:139-47. (IF 3.099)
Drey M, Sieber CC, Bertsch T, Bauer JM, Schmidmaier R; FiAT intervention group. Osteosarcopenia is more than sarcopenia and osteopenia alone. Aging Clin Exp Res. 2016;28:895-9. (IF 1.394) Eisenhofer G, Dekkers T, Peitzsch M, Dietz AS, Bidlingmaier M, Treitl M, Williams TA, Bornstein SR, Haase M, Rump LC, Willenberg HS, Beuschlein F, Deinum J, Lenders JW, Reincke M.
Mass spectrometry-based adrenal and peripheral venous steroid profiling for subtyping primary aldosteronism. Clin Chem. 2016;62:514-24. (IF 8.008)
Freier CP, Kuhn C, Endres S, Mayr D, Freise K, Jeschke U, Anz D. FOXP3+ cells recruited by CCL22 into breast cancer correlates with less tumor nodal infiltration. Anticancer Res.
2016;36:3139-45. (IF 1.937)
Götzberger M, Krueger S, Gärtner R, Reincke M, Pichler M, Assmann G, Mussack T, Zimmermann M, Gülberg V. Comparison of color-Doppler and qualitative and quantitative strain-elastography for differentiation of thyroid nodules in daily practice. Hormones (Athens).
2016;15:197-204. (IF 1.481)
Publikationen 2016
| 137
Publikationen 2016 Grützner E, Stirner R, Arenz L, Athanasoulia AP, Schrödl K, Berking C, Bogner JR, Draenert
R. Kinetics of human myeloid-derived suppressor cells after blood draw. J Transl Med. 2016;14:2.
(IF 3.786)
Hantel C, Ozimek A, Lira R, Ragazzon B, Jäckel C, Frantsev R, Reincke M, Bertherat J, Mussack T, Beuschlein F. TNF alpha signaling is associated with therapeutic responsiveness to vascular disrupting agents in endocrine tumors. Mol Cell Endocrinol. 2016;423:87-95. (IF 3.754)
Hantel C, Shapiro I, Poli G, Chiapponi C, Bidlingmaier M, Reincke M, Luconi M, Jung S, Beuschlein F. Targeting heterogeneity of adrenocortical carcinoma: Evaluation and extension of preclinical tumor models to improve clinical translation. Oncotarget. 2016;7:79292-304. (IF 5.168)
Haupt S, Söntgerath VSA, Leipe J, Schulze-Koops H, Skapenko A. Methylation of an intragenic alternative promoter regulates transcription of GARP. Biochim Biophys Acta. 2016;1859:223-34.
(IF 5.018)
Heidegger S, Gößl D, Schmidt A, Niedermayer S, Argyo C, Endres S, Bein T, Bourquin C.
Immune response to functionalized mesoporous silica nanoparticles for targeted drug delivery.
Nanoscale. 2016;8:938-48. (IF 7.367)
Honarpisheh M, Desai J, Marschner JA, Weidenbusch M, Lech M, Vielhauer V, Anders HJ, Mulay SR. Regulated necrosis-related molecule mRNA expression in humans and mice and in murine acute tissue injury and systemic autoimmunity leading to progressive organ damage, and progressive fibrosis. Biosci Rep. 2016;36:e00425. (IF 2.906)
Jäckel C, Schmitt-Nogueira M, Ehni N, Kraus C, Ranke J, Dohmann M, Noessner E, Nelson PJ. A vector platform for the rapid and efficient engineering of stable complex transgenes. Sci Rep. 2016;6:34365. (IF 4.259)
Jung S, Nagy Z, Fassnacht M, Zambetti G, Weiss M, Reincke M, Igaz P, Beuschlein F, Hantel C.
Preclinical progress and first translational steps for a liposomal chemotherapy protocol against adrenocortical carcinoma. Endocr Relat Cancer. 2016;23:825-37. (IF 5.267)
Kumar Vr S, Darisipudi MN, Steiger S, Devarapu SK, Tato M, Kukarni OP, Mulay SR, Thomasova D, Popper B, Demleitner J, Zuchtriegel G, Reichel C, Cohen CD, Lindenmeyer MT, Liapis H, Moll S, Reid E, Stitt AW, Schott B, Gruner S, Haap W, Ebeling M, Hartmann G, Anders HJ. Cathepsin S cleavage of protease-activated receptor-2 on endothelial cells promotes microvascular diabetes complications. J Am Soc Nephrol. 2016;27:1635-49. (IF 8.966)
Kunisch R, Guder P, Schinke K, Nörenberg D, Ruf VC, Alig S, Bauer HJ, Kirchner SK, Kruger S, Noerenberg D, Singer K, Tiedt S, Weckbach L, Wypior G, Angstwurm M. Reform des chirurgischen Tertials im Praktischen Jahr an der Ludwig-Maximilians-Universität München.
Zentralbl Chir. 2016;141:310-4. (IF 0.405)
Lichtenauer UD, Gerum S, Asbach E, Manolopoulou J, Fourkiotis V, Quinkler M, Bidlingmaier M, Reincke M. The clinical value of salivary aldosterone in diagnosis and follow-up of primary aldosteronism. Horm Metab Res. 2016;48:638-43. (IF 2.268)
Li P, Xiao Z-T, Braciak TA, Ou QJ, Chen G, Oduncu FS. Association between Ki67 index and clinicopathological features in colorectal cancer. Oncol Res Treat. 2016;39:696-702. (IF 1.667) Marschner JA, Schäfer H, Holderied A, Anders HJ. Optimizing mouse surgery with online rectal temperature monitoring and preoperative heat supply. Effects on post-ischemic acute kidney injury. PLoS One. 2016;11:e0149489. (IF 2.806)
138 |
Moog P, Eren O, Witt M, Rauschel V, Kossegg S, Straube A, Grünke M, Schulze-Koops H.
Assessment of autonomic function in a cohort of patients with ANCA-associated vasculitis. Clin Auton Res. 2016;26:279. (IF 1.276)
Mulay SR, Desai J, Kumar SV, Eberhard JN, Thomasova D, Romoli S, Grigorescu M, Kulkarni OP, Popper B, Vielhauer V, Zuchtriegel G, Reichel C, Bräsen JH, Romagnani P, Bilyy R, Munoz LE, Herrmann M, Liapis H, Krautwald S, Linkermann A, Anders HJ. Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis. Nat Commun. 2016;7:10274. (IF 12.124)
Mulay SR, Eberhard JN, Desai J, Marschner JA, Kumar SV, Weidenbusch M, Grigorescu M, Lech M, Eltrich N, Müller L, Hans W, Hrabě de Angelis M, Vielhauer V, Hoppe B, Asplin J, Burzlaff N, Herrmann M, Evan A, Anders HJ. Hyperoxaluria requires TNF receptors to initiate crystal adhesion and kidney stone disease. J Am Soc Nephrol. Epub 2016 Sep 9. (IF 8.966) Mulay SR, Eberhard JN, Pfann V, Marschner JA, Darisipudi MN, Daniel C, Romoli S, Desai J, Grigorescu M, Kumar SV, Rathkolb B, Wolf E, Hrabě de Angelis M, Bäuerle T, Dietel B, Wagner CA, Amann K, Eckardt KU, Aronson PS, Anders HJ*, Knauf F*. Oxalate-induced chronic kidney disease with its uremic and cardiovascular complications in C57BL/6 mice. Am J Physiol Renal Physiol. 2016;310:F785-F795. * geteilte Autorenschaft, (IF 3.611)
Mulay SR, Romoli S, Desai J, Honarpisheh MM, Kumar SV, Anders HJ, Thomasova D. Murine double minute-2 inhibition ameliorates established crescentic glomerulonephritis. Am J Pathol.
2016;186:1442-53. (IF 4.057)
Perez-Rivas LG, Rhayem Y, Sabrautzki S, Hantel C, Rathkolb B, Hrabě de Angelis M, Reincke M, Beuschlein F, Spyroglou A. Genetic characterization of a mouse line with primary aldosteronism.
J Mol Endocrinol. Epub 2016 Dec 13. (IF 3.577)
Proft F, Grunke M, Reindl C, Mueller F, Kriegmair M, Leipe J, Weinert P, Schulze-Koops H, Witt M. The influence of long distance running on sonographic joint and tendon pathology: Results from a prospective study with marathon runners. BMC Musculoskelet Disord. 2016,17:272. (IF 1.739)
Rapp M, Grassmann S, Chaloupka M, Layritz P, Kruger S, Ormanns S, Rataj F, Janssen KP, Endres S, Anz D, Kobold S. C-C chemokine receptor type-4 transduction of T cells enhances interaction with dendritic cells, tumor infiltration and therapeutic efficacy of adoptive T cell transfer. Cancer Immunol Immunother. 2016;5:e1105428. (IF 4.711)
Rhayem Y, Perez-Rivas LG, Dietz A, Bathon K, Gebhard C, Riester A, Mauracher B, Gomez-Sanchez C, Eisenhofer G, Schwarzmayr T, Calebiro D, Strom TM, Reincke M, Beuschlein F. PRKACA somatic mutations are rare findings in aldosterone-producing adenomas. J Clin Endocrinol Metab. 2016;101:3010-7. (IF 5.455)
Ribeiro A, Merkle M, Motamedi N, Nitschko H, Köppel S, Wörnle M. BK virus infection activates the TNFα/TNF receptor system in Polyomavirus-associated nephropathy. Mol Cell Biochem.
2016;411:191-9. (IF 2.669)
Riemekasten G, Aringer M, Baerwald CG, Meyer-Bahblurg A, Bergner A, Feuchtenberger M, Gebhardt C, Hellmich B, Keyßer G, Lorenz HM, Kneitz C, Witte T, Müller-Ladner U, Schneider M, Braun J, Rautenstrauch J, Specker C, Schulze-Koops H. Rheumatologie - Integration in die studentische Ausbildung (RISA): Zur aktuellen Struktur der internistischen Rheumatologie an deutschen Hochschulen (RISA III). Z Rheumatol. 2016;75:493-501. (IF 0.716)
Romagnani P, Giglio S, Angelotti ML, Provenzano A, Becherucci F, Mazzinghi B, Müller S, Amann K, Weidenbusch M, Romoli S, Lazzeri E, Anders HJ. Next generation sequencing and functional analysis of patient urine renal progenitor-derived podocytes to unravel the diagnosis underlying refractory lupus nephritis. Nephrol Dial Transplant. 2016;31:1541-5. (IF 4.470)
Publikationen 2016
| 139
Publikationen 2016 Ronchi CL, Di Dalmazi G, Faillot S, Sbiera S, Assié G, Weigand I, Calebiro D, Schwarzmayr T,
Appenzeller S, Rubin B, Waldmann J, Scaroni C, Bartsch DK, Mantero F, Mannelli M, Kastelan D, Chiodini I, Bertherat J, Reincke M, Strom TM, Fassnacht M, Beuschlein F; European Network for the Study of Adrenocortical Tumors (ENSAT). Genetic landscape of sporadic unilateral adrenocortical adenomas without PRKACA p.Leu206Arg mutation. J Clin Endocrinol Metab.
2016;101:3526-38. (IF 5.455)
Rosada A, Kassner U, Banisch D, Bender A, Steinhagen-Thiessen E, Vogt A. Quality of life in patients treated with lipoprotein apheresis. J Clin Lipidol. 2016;10:323-9.e6. (IF 5.812)
Roskopf CC, Braciak TA, Fenn NC, Kobold S, Fey GH, Hopfner KP, Oduncu FS. Dual-targeting triplebody 33-3-19 mediates selective lysis of biphenotypic CD19+ CD33+ leukemia cells.
Oncotarget. 2016;7:22579-89. (IF 5.168)
Schiller CB, Braciak TA, Fenn NC, Seidel UJE, Roskopf CC , Wildenhain S, Honegger A, Schubert IA, Schele A, Lämmermann K, Fey GH, Jacob U, Lang P, Hopfner K-P, Oduncu FS. CD19-specific triplebody SPM-1 recruits NK and γδ T cells for rapid and efficient lysis of malignant B-lymphoid cells. Oncotarget. 2016;7:83392-408. (IF 5.168)
Schloot NC, Pham MN, Hawa MI, Pozzilli P, Scherbaum WA, Schott M, Kolb H, Hunter S, Schernthaner G, Thivolet C, Seissler J*, Leslie RD*. Inverse relationship between organ-specific autoantibodies and systemic immune mediators in type 1 diabetes and type 2 diabetes: Action LADA 11. Diabetes Care. 2016;39:1932-39. (IF 11.857) *geteilte Letztautorenschaft
Schönermarck U, Dengler C, Gmeinwieser A, Praun S, Schelling G, Fischereder M, Boulesteix AL, Dolch ME. Exhaled breath volatile organic and inorganic compound composition in end-stage renal disease. Clin Nephrol. 2016;86:132-40. (IF 1.066)
Schulze-Koops H, Strand V, Nduaka C, DeMasi R, Wallenstein G, Kwok K, Wang L. Analysis of haematological changes in tofacitinib-treated patients with rheumatoid arthritis across phase 3 and long-term extension studies. Rheumatology. Epub 2016 Oct 22. (IF 4.818)
Stemberger M, Möhnle P, Tschöp J, Ney L, Spannagl M, Reincke M. Successful bleeding control with recombinant porcine factor VIII in reduced loading doses in two patients with acquired haemophilia A and failure of bypassing agent therapy. Haemophilia. 2016;22:e472-4. (IF 3.569) Störmann S, Stankiewicz M, Raes P, Berchtold C, Kosanke Y, Illes G, Loose P, Angstwurm MW.
How well do final year undergraduate medical students master practical clinical skills? GMS J Med Educ. 2016;33:Doc58. (IF -)
Sturm A, Dechant C, Proft F, Schulze-Koops H, Hoffmann U, Czihal M. Gender differences in giant cell arteritis revisited: a case control study. Clin Exp Rheumatol. 2016;34 (Suppl 97):S70-2.
(IF 2.634)
Then C, Rottenkolber M, Lechner A, Meisinger C, Heier M, Koenig W, Peters A, Rathmann W, Bidlingmaier M, Reincke M, Seissler J. Altered relation of the renin-aldosterone system and vasoactive peptides in type 2 diabetes: The KORA F4 study. Atherosclerosis. 2016;252:88-96.
(IF 4.239)
Then C, Rottenkolber M, Lechner A, Meisinger C, Heier M, Koenig W, Peters A, Rathmann W, Bidlingmaier M, Reincke M, Seissler J. Dataset of the associations of aldosterone to renin ratio with MR-proANP and MR-proADM. Data Brief. 2016;8:1395-99. (IF -)
Thomasova D, Ebrahim M, Fleckinger K, Li M, Molnar J, Popper B, Liapis H, Kotb AM, Siegerist F, Endlich N, Anders HJ. MDM2 prevents spontaneous tubular epithelial cell death and acute kidney injury. Cell Death Dis. 2016;7:e2482. (IF 5.965)
140 |
Tufman A, Huber RM, Völk S, Aigner F, Edelmann M, Gamarra F, Kiefl R, Kahnert K, Tian F, Boulesteix AL, Endres S, Kobold S. Interleukin-22 is elevated in lavage from patients with lung cancer and other pulmonary diseases. BMC Cancer. 2016;16:409. (IF 3.288)
Wiedemann G, Jacobi S, Chaloupka M, Hamm S, Strobl S, Baumgartner R, Rothenfusser S, Duewell P, Endres S, Kobold S. A novel TLR7 agonist reverses NK cell anergy and cures lymphoma-bearing mice. Oncoimmunology. 2016;5:e1189051. (IF 7.719)
Wiedemann G, Knott M, Vetter V, Rapp M, Haubner S, Fesseler J, Kühnemuth B, Layritz P, Thaler R, Kruger S, Ormanns S, Mayr D, Endres S, Anz D. Cancer cell-derived IL-1 induces CCL22 and the recruitment of regulatory T cells. Oncoimmunology 2016;5:e1175794. (IF 7.719) Williams TA, Peitzsch M, Dietz AS, Dekkers T, Bidlingmaier M, Riester A, Treitl M, Rhayem Y, Beuschlein F, Lenders JW, Deinum J, Eisenhofer G, Reincke M. Genotype-specific steroid profiles associated with aldosterone-producing adenomas. Hypertension. 2016;67:139-45. (IF 6.857)
Witt M, Frielinghausen J, Mueller R, Mueller F, Proft F, Schulze-Koops H, Grunke M, Clevert A. Evaluation of a novel semi-automated ultrasound system for the detection of synovitis: A prospective study involving 45 patients with rheumatoid arthritis. Ultrasound Int Open.
2016;2:E117-E123. (IF -)
Wölfel T, Beltermann E, Lottspeich C, Vietz E, Fischer MR, Schmidmaier R. Medical ward round competence in internal medicine - an interview study towards an interprofessional development of an Entrustable Professional Activity (EPA). BMC Med Educ. 2016;16:174. (IF 1.572)
Yuen KC, Frystyk J, Rhoads SA, Bidlingmaier M. Pegvisomant-primed glucagon stimulation test in assessing GH reserve and GH/IGF kinetics in adults suspected of GH deficiency. Pituitary.
2016;19:65-74. (IF 2.481)
Zeder AJ, Hilge R, Schrader S, Bogner JR, Seybold U. Medium-grade tubular proteinuria is common in HIV-positive patients and specifically associated with exposure to tenofovir disoproxil fumarate. Infection. 2016;44:641-9. (IF 2.468)
Zengin A, Kropp B, Chevalier Y, Junnila R, Sustarsic E, Herbach N, Fanelli F, Mezzullo M, Milz S, Bidlingmaier M, Bielohuby M. Low-carbohydrate, high-fat diets have sex-specific effects on bone health in rats. Eur J Nutr. 2016;55:2307-20. (IF 4.370)